You are here: Industry Insights > antibodies

News List

Global COVID-19 Therapeutics Market worth $14.6 billion by 2022 - Exclusive Report by InsightAce Analytic prnewswire
January 19, 2022
The newly published report titled "Global COVID-19 Therapeutics Market– By Trends, Industry Competition Analysis, Clinical Trial/Pipeline Analysis, Revenue (US$ Billions) and Forecast Till 2030." of InsightAce...
Prellis, Bristol Myers Squibb collaborate to discover antibodies pharmaceutical-business-review
January 14, 2022
Prellis Biologics and Bristol Myers Squibb have signed a multi-target collaboration and license agreement to discover antibodies.
COVID-19 can trigger self-attacking antibodies WorldPharmaNews
January 04, 2022
Infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond the initial infection and recovery - even among people who had mild symptoms or no symptoms at all...
COVID-19 Vaccine Developed by WestVac BioPharma Has High Titer Neutralizing Antibodies Against Omicron prnasia
December 27, 2021
WestVac BioPharma Co., Ltd. has achieved a significant progress in the second generation COVID-19 vaccine against the Omicron mutant strain.
Discovering new drugs with Darwin WorldPharmaNews
December 08, 2021
Our body must constantly defend itself against bacteria and viruses. It generates millions of different antibodies, which are selected to recognise the enemy and trigger the best possible immune response. Scientists use these antibodies to for ...
SPARC enters into licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target expresspharma
December 06, 2021
Under the agreement, Biomodifying is eligible for an upfront payment, milestone payments on pre-specified clinical, regulatory, and commercial milestones, as well as royalties on sales.
Omicron Unlikely to Cause Severe Illness in Vaccinated People, BioNTech Founder Says FirstWordPharma
December 01, 2021
Several scientists said the new Omicron strain of SARS-CoV-2 could lead to more infections among vaccinated people, but some suggested there were reasons to believe the shots would protect against severe disease...
EMA stops rolling review of Lilly’s antibodies for Covid-19 Pharmaceutical-Technology
November 04, 2021
The European Medicines Agency (EMA) has ended the rolling review of the marketing authorisation application for Eli Lilly Netherlands’ antibodies, bamlanivimab and etesevimab, to treat Covid-19.
AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies prnasia
September 28, 2021
AbCellera (Nasdaq: ABCL) and Everest Medicines Limited (HKEX 1952.HK, "Everest") announced today that they have entered into a multi-year collaboration and license agreement...
SARS-CoV-2 Antibodies Identified Before Cases Recognized in U.S. drugs
June 16, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies were identified in individuals before the first cases of infection were recognized, according to a study published online June 15 in Clinical Infectious Diseases.

Previous page 1 2 3 4 5 6 Next page